FDA Tip-Toes In China To Push Data Integrity, Harmonization
Executive Summary
US FDA warning letters to Chinese firms may be on the increase, but ties with the Chinese regulator appear to be growing. US FDA showcases how to get more done in fast-changing China via aligning with China FDA's aspiration for quality and international harmonization.
You may also be interested in...
Warnings, Recalls: Consumer Health Regulatory News
Rodent feces in Chinese OTC firm’s facility; and Major, Rugby recall Pharmatech-made OTCs.
Warnings, Recalls: Consumer Health Regulatory News
Rodent feces in Chinese OTC firm’s facility; and Major, Rugby recall Pharmatech-made OTCs.
US FDA's China Staff Increase Takes Hold As Gottlieb Boosts Border Security
After receiving delayed visas, additional FDA is inspectors and other staff can relocate to China office; Gottlieb also announces increase in international mail facility staff.